![Michael Mitchell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Mitchell
Fondateur chez
Liberate Bio, Inc.
Profil
Michael Mitchell is the founder of Liberate Bio, Inc. He currently holds two positions as Director at Cota, Inc. and Board Member at Children's Organ Transplant Association.
Previously, he worked as an Investment Banking Analyst at Cain Brothers & Co. LLC and Morgan Keegan & Co. (Private Equity), a Principal at Essex Woodlands Management, Inc., and a Senior Associate at Enhanced Healthcare Partners.
Mr. Mitchell received his undergraduate degree from UNC School of Law in 2011 and his MBA from the University of Pennsylvania Graduate School of Education in 2018.
Postes actifs de Michael Mitchell
| Sociétés | Poste | Début |
|---|---|---|
Children's Organ Transplant Association
 Children's Organ Transplant Association Miscellaneous Commercial ServicesCommercial Services The Children's Organ Transplant Association is a nonprofit organization that provides no-cost fundraising assistance and family support to children, young adults, and individuals of any age with certain single-gene disorders who require organ, bone marrow, or stem cell transplants. The private company is based in Bloomington. The organization helps families raise funds to cover transplant-related expenses, including medical bills, medications, lodging, transportation, household costs, and living donor expenses. It operates through a nationwide network of community volunteers and donors, offering ongoing financial safety nets and lifelong support throughout the transplant process. The website serves as a resource hub with patient information, fundraising tools, expense estimators, and professional resources for families, volunteers, and transplant professionals. | Directeur/Membre du Conseil | 01/06/2021 |
Cota, Inc.
 Cota, Inc. Packaged SoftwareTechnology Services Develops software for cancer patients to analyze the disease | Directeur/Membre du Conseil | 01/06/2021 |
Liberate Bio, Inc.
 Liberate Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Fondateur | - |
Anciens postes connus de Michael Mitchell
| Sociétés | Poste | Fin |
|---|---|---|
Enhanced Healthcare Partners
 Enhanced Healthcare Partners Investment ManagersFinance Enhanced Healthcare Partners invests in lower middle-market companies located in the United States with an enterprise value of USD 50 - 250 million. The firm focuses on the healthcare sector. It participates in MBO, recapitalization and growth capital requirements with an investment size of USD 20 - 75 million. | Analyste en capital-investissement | 01/06/2016 |
Cain Brothers & Co. LLC
 Cain Brothers & Co. LLC Investment Banks/BrokersFinance Provides investment banking and financial advisory services to the healthcare industry | Analyste en capital-investissement | 01/12/2013 |
Morgan Keegan & Co. (Private Equity)
 Morgan Keegan & Co. (Private Equity) Investment ManagersFinance Morgan Keegan & Co. focuses on investments in established service and manufacturing companies. They do not invest in real estate, financial services or high-technology industries. The Morgan Keegan Mezzanine Fund provides mezzanine financing to small and mid-sized companies. Investments are used to finance buyouts, recapitalizations, strategic acquisitions and later stage growth and range from $1 million to $10 million. The Fund may make co-investments to complete larger transactions. Companies must have revenues of at least $10 million. The Fund focuses on established service and manufacturing companies and will not invest in real estate, financial services or high-technology industries. Preferred locations are the Southeast, Mid-Atlantic, Midwest and Southwest. The most common form of security used is subordinated debt with detachable warrants to purchase an equity ownership position. The Fund does not actively manage the businesses but does require a board seat or observation rights. Targeted maturity is 3 to 5 years. | Analyste en capital-investissement | 01/08/2012 |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Private Equity Investor | - |
Formation de Michael Mitchell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Cain Brothers & Co. LLC
Cain Brothers & Co. LLC Investment Banks/BrokersFinance Provides investment banking and financial advisory services to the healthcare industry | Finance |
Cota, Inc.
Cota, Inc. Packaged SoftwareTechnology Services Develops software for cancer patients to analyze the disease | Technology Services |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Finance |
Morgan Keegan & Co. (Private Equity)
Morgan Keegan & Co. (Private Equity) Investment ManagersFinance Morgan Keegan & Co. focuses on investments in established service and manufacturing companies. They do not invest in real estate, financial services or high-technology industries. The Morgan Keegan Mezzanine Fund provides mezzanine financing to small and mid-sized companies. Investments are used to finance buyouts, recapitalizations, strategic acquisitions and later stage growth and range from $1 million to $10 million. The Fund may make co-investments to complete larger transactions. Companies must have revenues of at least $10 million. The Fund focuses on established service and manufacturing companies and will not invest in real estate, financial services or high-technology industries. Preferred locations are the Southeast, Mid-Atlantic, Midwest and Southwest. The most common form of security used is subordinated debt with detachable warrants to purchase an equity ownership position. The Fund does not actively manage the businesses but does require a board seat or observation rights. Targeted maturity is 3 to 5 years. | Finance |
UNC School of Law
 UNC School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Graduate School of Education
 University of Pennsylvania Graduate School of Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enhanced Healthcare Partners
Enhanced Healthcare Partners Investment ManagersFinance Enhanced Healthcare Partners invests in lower middle-market companies located in the United States with an enterprise value of USD 50 - 250 million. The firm focuses on the healthcare sector. It participates in MBO, recapitalization and growth capital requirements with an investment size of USD 20 - 75 million. | Finance |
Children's Organ Transplant Association
Children's Organ Transplant Association Miscellaneous Commercial ServicesCommercial Services The Children's Organ Transplant Association is a nonprofit organization that provides no-cost fundraising assistance and family support to children, young adults, and individuals of any age with certain single-gene disorders who require organ, bone marrow, or stem cell transplants. The private company is based in Bloomington. The organization helps families raise funds to cover transplant-related expenses, including medical bills, medications, lodging, transportation, household costs, and living donor expenses. It operates through a nationwide network of community volunteers and donors, offering ongoing financial safety nets and lifelong support throughout the transplant process. The website serves as a resource hub with patient information, fundraising tools, expense estimators, and professional resources for families, volunteers, and transplant professionals. | Commercial Services |
Liberate Bio, Inc.
Liberate Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
